Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

195.700
-6.100-3.02%
Volume:179.62K
Turnover:34.94M
Market Cap:17.87B
PE:-4.20
High:201.800
Open:201.800
Low:190.200
Close:201.800
52wk High:376.800
52wk Low:158.500
Shares:91.31M
HK Float Shares:91.31M
Volume Ratio:0.31
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-46.559
ROE:-65.93%
ROA:-24.30%
PB:10.53
PE(LYR):-4.20
PS:18.14

Loading ...

Market Analysis: Meta's AI Compute Sale Not a Bearish Signal; Healthcare Stocks Surge on Multiple Catalysts

Stock News
·
Jul 02

Movement Alert|Duality Biotherapeutics-B Rises 15.01% in Regular Trading, ADC Sector Breakthrough and Biotech Rebound Drive Surge

Market Focus
·
Jul 02

Movement Alert|Duality Biotherapeutics-B Rises 5.65% in Regular Trading, Buyback Action Signals Management Confidence Amid Biotech Rebound

Market Focus
·
Jun 29

DualityBio-B (09606) Allocates HK$11.99 Million for Share Buyback on June 26

Stock News
·
Jun 29

Duality Biotherapeutics Files HKEX Next-day Disclosure Return on Share Repurchase for Treasury Shares

Reuters
·
Jun 29

DualityBio-B Announces Appointment of Leung Chi Kit as Joint Company Secretary

Stock News
·
Jun 26

Duality Biotherapeutics Announces Company-Secretary Transition, Secures New HKEX Waiver, Relocates Hong Kong Office

Bulletin Express
·
Jun 26

DualityBio grants 283,500 RSUs worth HK$46.16 million to 38 employees under 2025 Share Scheme

Bulletin Express
·
Jun 26

Duality Biotherapeutics Clears All AGM Resolutions, Secures Mandates for Share Repurchase and Issuance

Bulletin Express
·
Jun 26

Duality Biotherapeutics Appoints Leung Chi Kit Joint Company Secretary, Replacing Tsang Wing Man

Reuters
·
Jun 26

Duality Biotherapeutics Grants 283,500 Rsus Under 2025 Share Scheme

Reuters
·
Jun 26

Movement Alert|Duality Biotherapeutics-B Declines 5.18% in Regular Trading, Trading at 160.0 HKD

Market Focus
·
Jun 26

HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%

Tiger Newspress
·
Jun 23

DualityBio-B Repurchases 53,900 Shares at Cost of HK$9.77 Million

Stock News
·
Jun 16

Duality Biotherapeutics files HKEX next-day disclosure return on share buyback

Reuters
·
Jun 16

Duality Biotherapeutics Advances Shanghai STAR Market Listing Plan

MT Newswires Live
·
Jun 15

Duality Biotherapeutics gains Shanghai Stock Exchange acceptance for STAR Market A-share IPO

Bulletin Express
·
Jun 12

DUALITYBIO-B Submits Application for A-Share Listing on Shanghai's STAR Market

Stock News
·
Jun 12

Duality Biotherapeutics - Shanghai Stock Exchange Accepts Application Materials for RMB Share Issue

THOMSON REUTERS
·
Jun 12

DualityBio's Shanghai STAR Market IPO Application Accepted, Focused on ADC Therapeutics

Stock News
·
Jun 12